Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions

Journal of Neuroscience Research

Volumn 60, Issue 1, 2000, Pages 73-86

  Hu, Qubai ^a   Jin, Lee Way ^a   Starbuck, Marilyn Y ^a   Martin, George M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer disease; Cerebellum; Diffuse plaques; FE65; Quantitative RT PCR

Indexed keywords

ADAPTOR PROTEIN; AMYLOID BETA PROTEIN; MESSENGER RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CAUDATE NUCLEUS; CEREBELLUM; CEREBELLUM CORTEX; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENILE PLAQUE; TEMPORAL CORTEX;

ALZHEIMER DISEASE; BRAIN; CAUDATE NUCLEUS; CEREBELLUM; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

EID: 0034123008     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000401)60:1<73::AID-JNR8>3.0.CO;2-S     Document Type: Article

References (54)

1. Bird TD, Stranahan S, Sumi SM, Raskind M. 1983. Alzheimer's desease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Nenrol 14:284-293.
2. Borg JP, Ooi J, Levy E, Margolis B. 1996. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16:6229-6241.
3. Braak H, Braak E. 1997. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357.
4. Braak H, Braak E, Bohl J, Laug W. 1989. Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci 93:277-287.
5. Bressler SL, Cray MD, Sopher BL, Hu Q, Hearn MG, Pham DG, Dinulos MB, Fukuchi K, Sisodia SS, Miller MA, Disteche CM, Martin GM. 1996. cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet 5:1589-1598.
6. Carpenter AF, Carpenter PW, Markesbery WR. 1993. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 52:601-608.
7. Coleman PD, Flood DG. 1987. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 8:521-545.
8. Cowburn RF, O'Neill C, Ravid R, Alafuzoff I, Winblad B, Fowler CJ. 1992. Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease. J Neurochem 58: 1409-1419.
9. De Strooper B, Umans L, Van Leuven F, Van Den Berghe H. 1993. Study of the synthesis and secretion of normal and artiticial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J Cell Biol 121:295-304.
10. Dewar D, Chalmers DT, Shand A, Graham DI, McColloch J 1990. Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellum. Ann Neurol 28:805-810.
11. Duilio A, Zambrano N, Mogavero AR, Ammendola R, Cimino F, Russo T. 1991. A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res 19:5269-5274.
12. Ermekova KS, Zambrano N, Linn H, Minopoli G, Gertler F, Russo T, Sudol M. 1997. The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J Biol Chem 272:32869-32877.
13. Fiore F, Zambrano N, Minopoli G, Donini V, Duilio A, Russo T. 1995. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 270:30853-30856.
14. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangenekar VM, Mattson MP. 1998. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med 4:957-962.
15. Hardy J. 1997. Amyloid, the presinilins and Alzheimer's disease. Trends Neurosci 20:154-159.
16. Hank SI, Mitchell MJ, Kalaria RN. 1989. Ouabain binding in the human brain. Effects of Alzheimer's disease and aging. Arch Neurol 46:951-954.
17. Higgins CA, Large CH, Rupniak HT, Barnes JC. 1997. Apolipoprotein E and Alzheimer's disease: a review of recent studies. Pharmacol Biochem Behav 56:675-685.
18. Hsu SM, Raine L, Fanger H. 1981. Use of avidin biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
19. Hu Q, Hearn MG, Jin L-W, Bressler SL, Martin GM. 1999. Alternatively spliced isoforms of FE65 serve as neuron-specific and non-neuronal markers. J Neurosci Res 58:632-640.
20. Hu Q, Kukull WA, Bressler SL, Gray MD, Cam JA, Larson EB, Martin GM, Deeb SS. 1998. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet 103:295-303.
21. Joachim CL, Morris JH, Selkoe DJ. 1989. Difuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 135: 309-319.
22. Koo EH, Squazzo SL. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269: 17386-17389.
23. Kosik KS. 1999. A notable cleavage: winding up with β-amyloid. Proc Natl Acad Sci USA 96:2574-2576.
24. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK. 1995. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82:331-340.
25. Krieger M, Herz J. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601-637.
26. Lai A, Sisodia SS, Trowbridge IS. 1995. Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain. J Biol Chem 270:3565-3573.
27. Lambert J-C, Mann D, Goumidi L, Pasquier F, Frigard B, Cottel D, Iwatsubo T, Amouyel P, Chartier-Harlin M-C. 1999. A FE65 deletion polymorphism is associated with reduced Aβ loading and a lowering of the risk of developing sporadic late-onset Alzheimer's disease. Soc Neurosci 25:836.
28. Larner AJ. 1997. The cerebellum in Alzheimer's disease. Dement Geriatr Cogn Disord 8:203-209.
29. LeBlanc AC, Gambetti P. 1994. Production of Alzheimer 4-kDa beta-amyloid peptide requires the C-terminal cytosolic domain of the amyloid precursor protein, Biochem Biophys Res Commun 204:1371-1380.
30. Mackenzie IR, Hao C, Munoz DG. 1995. Role of microglia in senile plaque formation. Neurobiol Aging 16:797-804.
31. Morgan DG, Finch CE, Johnson SA. 1991. RNA metabolism in Alzheimer's disease: selective increase in GFAP mRNA. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM, editors. Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. New York: Wiley. p 407-416.
32. National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. 1997. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18(4 Suppl):S1-S2.
33. Nichols NR, Day JR, Laping NJ, Johnson SA, Finch CE. 1993. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 14:421-429.
34. Nochlin D, Mackenzie AF, Bryant EM, Norwood TH, Sumi SM. 1993. A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination. Acta Neuropathol (Berlin) 86:645-650.
35. Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M. 1989. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 134:243-251.
36. Pearson RCA, Powell TPS. 1989. The neuroanatomy of Alzheimer's disease. Rev Neurosci 2:101-122.
37. Roses AD. 1998. Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg. Ann NY Acad Sci 855:738-743.
38. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. 1982. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105:313-330.
39. Russo T, Faraonio R, Minopoli G, De Candia P, De Renzis S, Zambrano N. 1998. Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's β-amyloid precursor protein. FEBS Lett 434:1-7.
40. Sabo SL, Lanier LM, Ikin AF, Khorkova O, Sahasrabudhe S, Greengard P, Buxbaum JD. 1999. Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem 274:7952-7957.
41. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. 1993. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653.
42. Selden N, Mesulam MM, Geula C. 1994. Human striatum: the distribution of neurofibrillary tangles in Alzheimer's disease. Brain Res 648:327-331.
43. Selkoe DJ. 1996. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298.
44. Selkoe DJ. 1998. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453.
45. Simeone A, Duilio A, Fiore F, Acampora D, De Felice C, Faraonio R, Paolocci F, Cimino F, Russo T. 1994. Expression of the neuron-specific FE65 gene marks the development of embryo ganglionic derivatives. Dev Neurosci 16:53-60.
46. Slemmon JR, Hughes CM, Campbell GA, Flood DG. 1994. Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. J Neurosci 14:2225-2235.
47. Spanakis E. 1993. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res 21:3809-3819.
48. Strickland DK, Ashcom JD, Williams S, Burgess WH, Migliorini M, Argraves WS. 1990. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 265:17401-17404.
49. Suenaga T, Hirano A, Llena JF, Ksiezak-Reding H, Yen SH, Dickson DW. 1990. Modified Bielschowsky and immunocytochemical studies on cerebellar plaques in Alzheimer's disease. J Neuropathol Exp Neurol 49:31-40.
50. Trommsdorf M, Borg JP, Margolis B, Herz J. 1998. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 273:33556-33560.
51. Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, Mlodzik B, De Leon MJ, Miller DC. 1999. Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations. Brain Res 818:41-50.
52. West MJ, Coleman PD, Flood DG, Troncoso JC. 1994. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772.
53. Zambrano N, Buxbaum JD, Minopoli G, Fiore F, De Candia P, De Renzis S, Faraonio R, Sabo S, Cheetham J, Sudol M, Russo T. 1997. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. J Biol Chem 272:6399-6405.
54. Zambrano N, Minopoli G, de Candia P, Russo T. 1998. The FE65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273:20128-20133.